EnhancerAtlas 2.0: an updated resource with typical enhancer annotation in 600 tissue/cell types across nine species

TagContent
EnhancerAtlas ID
HS051-15971 
Organism
Homo sapiens 
Tissue/cell
Fetal_thymus 
Coordinate
chr2:128164730-128166570 
TF binding sites/motifs
Number: 14             
TFJASPAR IDCoordinateMotif SequenceStrand-Log10(p-value)
EWSR1-FLI1MA0149.1chr2:128165606-128165624GCGTCCTTCCCGCCTTCC-6.01
KLF16MA0741.1chr2:128165572-128165583GCCCCGCCCCC+6.02
KLF16MA0741.1chr2:128165812-128165823GGGGGCGTGGC-6.62
KLF5MA0599.1chr2:128165572-128165582GCCCCGCCCC+6.02
RREB1MA0073.1chr2:128166244-128166264GCCCCCACCACCACCACCCC+6.45
SP3MA0746.2chr2:128165811-128165824TGGGGGCGTGGCG-6.57
SP8MA0747.1chr2:128165811-128165823TGGGGGCGTGGC-6.11
TFAP2AMA0003.3chr2:128165379-128165390AGCCTCAGGCA+6.32
ZNF263MA0528.1chr2:128165526-128165547TCCTCCTCCTCCTCCCCCACC-6.27
ZNF263MA0528.1chr2:128165532-128165553TCCTCCTCCCCCACCACCTCT-6.49
ZNF263MA0528.1chr2:128165472-128165493CTCCCTCCCTCCTTCTGCTCC-6.59
ZNF263MA0528.1chr2:128165529-128165550TCCTCCTCCTCCCCCACCACC-7.31
ZNF263MA0528.1chr2:128165580-128165601CCCTCCTCTTCCCCCTGCCCC-7.81
ZNF263MA0528.1chr2:128165523-128165544GCCTCCTCCTCCTCCTCCCCC-8.62
Number of super-enhancer constituents: 11             
IDCoordinateTissue/cell
SE_09644chr2:128164535-128166940CD14
SE_23461chr2:128165153-128165765Colon_Crypt_1
SE_23461chr2:128165766-128166677Colon_Crypt_1
SE_24012chr2:128165266-128166623Colon_Crypt_2
SE_24894chr2:128165065-128166599Colon_Crypt_3
SE_28345chr2:128164776-128166852Fetal_Intestine
SE_29146chr2:128164682-128166773Fetal_Intestine_Large
SE_43376chr2:128165019-128166813Lung
SE_50833chr2:128165107-128166882Sigmoid_Colon
SE_52838chr2:128165093-128165615Small_Intestine
SE_52838chr2:128165639-128166869Small_Intestine
Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder
Number of disease enhancers: 2             
ChromosomeStartEnd
chr2128165888128166200
chr2128164878128165800
Number: 1             
IDChromosomeStartEnd
GH02I127406chr2128164514128166975
Enhancer Sequence
GACCAGCTTG AACAACATAG TGAGACCCCA TCTCTACAAA AAATTAAAAA ATTAGCCAGG 60
TGTGGCGGTC CATGCCGGTA GTCCCAGCTA CTTGGGAGGC TGAGGCAGGA TGATCACTTG 120
CACCTGGGAC GTTGAGGCGG CAGTGAGCCG TGTTCGCGCC ACTGCACTCC AGCCTGGGTG 180
ACACTGCAAG ACCCTGTCTC AAAAAAAGTA GTCAAGGAGG CTGAGAGCCA GGAAGCCTCT 240
GGCCAGCAGG TGAGCAGGCC CTTTCCTGCT GCTGTGCATT GTATTTAAGA GAAAAGACAG 300
ATACGTCTGA TACCTTCAAA GGTGTTCTTC ATACAGCAGG TTGCAACCTA TTAATAGATC 360
ATAAAATCAG TTTAGTGTTT CATCATCATC ATCAAAAACC ACCACCAACA ACAAAAAGAC 420
CCAGAACAGA TAGTGTAAAG AGTGCATCCC TGCATTCCTG TATAGGGAGA AATATGGTTT 480
TGTGGAACCT TGTTGCGATG TAAAGTGTAC TTCTTAAGAT AAATACAGGG TTGAGGTTTT 540
TGAAATAAAG TTTGAACAGG ACCACCTTAA GCCACAGTGT AGACTTTCCA TAGGCCAAAA 600
CCTGGATCAC CAAGACAGTG TGCCCCAGGC TGCAGGCCAC ACTCCTGGGA GCCTCAGGCA 660
ACCTTGTGCA GGCCTGACTT CGAGACACTC TGAGCATGAG CTGGTTCCTG GGTAGCCTCC 720
CCTCTACCTC TCCCCGCTTG CCCTCCCTCC CTCCTTCTGC TCCTGTCTCT CCTCATCCCC 780
TCCCCGAGTT GCTGCCTCCT CCTCCTCCTC CCCCACCACC TCTCCCCGTC TCCGAGTTGC 840
CTGCCCCGCC CCCTCCTCTT CCCCCTGCCC CTCTCCGCGT CCTTCCCGCC TTCCCCCTCC 900
TCGTCTCCCC CCTCCCCGCC CGCGCCGTCT GCGTCCCTCC CGGGCCCAGA CGCGGCGCGG 960
TCAGGGGGCG CTGACTCACA GGCTGACTCA GCTGCAGGCG CGCTGCCAGG CGACGCAGCG 1020
GGCGGGTGGC CGGGCGCCGG CGGGCTCGCA GCCGGGCTGC TGGCAACGGT GCCGGCGGAG 1080
GTGGGGGCGT GGCGCGGGAT GGGCGGCGCG GGCCCTGCCG TGGTACCGCC TGGCAGCGTC 1140
CACCCCGCCG CTGGGGCGCC CTGGAGGCTC CTGGCCCTCC GTGGGGCCGT GACACCGGCG 1200
CTGCGGGGAG CGGTGGCCTC GCAGAGGCTG GGCATGGGAG GACGGCCGCC CCGGGTAAAG 1260
GACAGGGCCC TGGAAACGCG GGTCTGCCGG GAGCAGGGGA CAGGAAGGAG ACCGCGGCTC 1320
TCCCAGTCCT GCTGCCCCGG GCCTCCAGAC GGCCAGACTC TCCCCACACC GGCCTGGAGG 1380
GGGACGCGCC GACCCCAGCT GGGAGGGGTG GCTGGCTGCG TAGATCCGTT TGGGCCGCCT 1440
GCCTGGAAAG GCCCAGGTCC GGGCCTCGTC CTCCTCTTCA CACTCTCCCC CGATCTCCAA 1500
CCACCTTCAC CCTCGCCCCC ACCACCACCA CCCCCAGCTC CTCCTGGCCG CCTGCGGTCC 1560
AGCTGAGGCC CGCCTCCTCC AGGAAGTCTT CCTGGAGAGC CTGTCCTGGG TTAGGCCCGC 1620
CCAGAGCCAC CTGGGGCGAC TTATTTCATG GCACCTTCGA CCTTGCTCTC TGTCTGTTTT 1680
GTGTCTGGCT TCATCACCAA ACTGAGCCTC TTGGGGGCAG TGACCGGGTC TTAGGTCTTA 1740
GTTGGCCCTT AGGCGCTAGG GCTGAGAAGA CTTAGGCGGA CAGGAGATGA GACTGTGTAT 1800
TCGACGACAC ACTTTAGAGA TCCAGCCCGG AACACAGCCA 1840